Lilly Q1 ’17 Earnings Update
Lilly hosted its Q1 ’17 earnings call and provided an update to its diabetes portfolio including pipeline and LCM activities.
This content is for Read Less members only.
Already a member? Log in here
Category Archives: GLP-1RA
Lilly Increases Diabetes Manufacturing Investment in 2017
Lilly has announced intentions to invest $850M in its US operations in 2017 including $85M to expand the Trulicity device assembly operations. Additionally, Lilly announced the dedication of a $140M insulin cartridge facility.
This content is for Read Less members only.
Already a member? Log in here
Lilly Partners with Sansum for Diabetes Research in the Latino Population
Lilly and the William Sansum Diabetes Center in Santa Barbara, California have entered into a research collaboration to further understand the unmet needs related to diabetes in the Latino population.
This content is for Read Less members only.
Already a member? Log in here